Zeng-Hong Li

469 total citations
13 papers, 341 citations indexed

About

Zeng-Hong Li is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zeng-Hong Li has authored 13 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zeng-Hong Li's work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Zeng-Hong Li is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (4 papers). Zeng-Hong Li collaborates with scholars based in Hong Kong and China. Zeng-Hong Li's co-authors include Thian‐Sze Wong, Wei Gao, Jimmy Yu‐Wai Chan, Jimmy Yu Wai Chan, Jing Zhao, WI Wei, Wenbin Lei, Qing‐Ling Fu, Hao Qin and Jie Luo and has published in prestigious journals such as Sensors, BioMed Research International and Oncotarget.

In The Last Decade

Zeng-Hong Li

13 papers receiving 332 citations

Peers

Zeng-Hong Li

ONCOL

DERMA

SURGE

Phuong Vu Norway

Xiaoling Song China

Megan Ludwig United States

Çiğdem Irkkan Türkiye

Zu‐Lu Ye China

Mark Mansour Canada

Florian Roßner Germany

Yingru Xu China

Max Partridge United Kingdom

Phuong Vu Norway

Zeng-Hong Li

107 ×0.5

106 ×0.5

139 ×2.6

ONCOL

15 ×0.4

DERMA

20 ×0.5

SURGE

Citations per year, relative to Zeng-Hong Li Zeng-Hong Li (= 1×) peers Phuong Vu

Countries citing papers authored by Zeng-Hong Li

Since Specialization

Citations

This map shows the geographic impact of Zeng-Hong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeng-Hong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeng-Hong Li more than expected).

Fields of papers citing papers by Zeng-Hong Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeng-Hong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeng-Hong Li. The network helps show where Zeng-Hong Li may publish in the future.

Co-authorship network of co-authors of Zeng-Hong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zeng-Hong Li. A scholar is included among the top collaborators of Zeng-Hong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeng-Hong Li. Zeng-Hong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Gao, Wei, et al.. (2017). MicroRNA-138-5p controls sensitivity of nasopharyngeal carcinoma to radiation by targeting EIF4EBP1. Oncology Reports. 37(2). 913–920. 20 indexed citations

Zhao, Jing, Zeng-Hong Li, Jianhui Wu, et al.. (2017). Functional significance of the long non-coding RNA RP11-169D4.1 as a metastasis suppressor in laryngeal squamous cell carcinoma by regulating CDH1. Oncology Reports. 38(1). 211–220. 12 indexed citations

Gao, Wei, Zeng-Hong Li, Siqi Chen, et al.. (2017). Epstein-Barr virus encoded microRNA BART7 regulates radiation sensitivity of nasopharyngeal carcinoma. Oncotarget. 8(12). 20297–20308. 23 indexed citations

Li, Zeng-Hong, et al.. (2016). The clinical association of programmed cell death protein 4 (PDCD4) with solid tumors and its prognostic significance: a meta-analysis. Chinese Journal of Cancer. 35(1). 95–95. 22 indexed citations

Wong, Thian‐Sze, et al.. (2016). The Efficacy of Triamcinolone Acetonide in Keloid Treatment: A Systematic Review and Meta-analysis. Frontiers in Medicine. 3. 71–71. 48 indexed citations

Gao, Wei, et al.. (2016). Decreased brain-expressed X-linked 4 (BEX4) expression promotes growth of oral squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 35(1). 92–92. 17 indexed citations

Li, Zeng-Hong, Wei Gao, Jing Zhao, et al.. (2016). MicroRNA 744-3p promotes MMP-9-mediated metastasis by simultaneously suppressing PDCD4 and PTEN in laryngeal squamous cell carcinoma. Oncotarget. 7(36). 58218–58233. 39 indexed citations

Wang, Bin, Weixiong Chen, Jing Zhao, et al.. (2016). miR-375 and miR-205 Regulate the Invasion and Migration of Laryngeal Squamous Cell Carcinoma Synergistically via AKT-Mediated EMT. BioMed Research International. 2016. 1–11. 28 indexed citations

Luo, Jie, Jianhui Wu, Zeng-Hong Li, et al.. (2014). miR-375 Suppresses IGF1R Expression and Contributes to Inhibition of Cell Progression in Laryngeal Squamous Cell Carcinoma. BioMed Research International. 2014. 1–11. 45 indexed citations

10.

Gao, Wei, Zeng-Hong Li, Wai Kuen Ho, Jimmy Yu‐Wai Chan, & Thian‐Sze Wong. (2012). Biomarkers for Use in Monitoring Responses of Nasopharyngeal Carcinoma Cells to Ionizing Radiation. Sensors. 12(7). 8832–8846. 12 indexed citations

11.

Gao, Wei, Zeng-Hong Li, Jimmy Yu Wai Chan, Wai Kuen Ho, & Thian‐Sze Wong. (2012). mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer. PubMed. 2012. 1–7. 19 indexed citations

12.

Li, Zeng-Hong, et al.. (2012). Hypoxia in Head and Neck Squamous Cell Carcinoma. Europe PMC (PubMed Central). 2012. 1–8. 34 indexed citations

13.

Wong, Thian‐Sze, et al.. (2012). Epigenetic Dysregulation in Laryngeal Squamous Cell Carcinoma. Journal of Oncology. 2012. 1–10. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact